[Artificial polynucleotides as inducers of interferon].
D000818:Animals; D004285:Dogs; D004357:Drug Synergism; D006563:Herpes Zoster Ophthalmicus / Q000188:drug therapy; D006801:Humans; D007369:Interferon Inducers / Q000494:pharmacology*; D007372:Interferons / Q000096:biosynthesis* / Q000627:therapeutic use; D007970:Leukopenia / Q000139:chemically induced; D051379:Mice; D009355:Neomycin / Q000494:pharmacology; D011063:Poly A-U / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology; D011072:Poly U / Q000494:pharmacology; D011119:Polynucleotides / Q000009:adverse effects / Q000494:pharmacology*; D014176:Protein Biosynthesis; D011817:Rabbits; D012790:Shwartzman Phenomenon / Q000139:chemically induced; D000637:Transaminases / Q000097:blood; D014777:Virus Diseases / Q000188:drug therapy
D007369:Interferon Inducers; D011119:Polynucleotides; D011063:Poly A-U; D011072:Poly U; D007372:Interferons; D000637:Transaminases; D009355:Neomycin; D011070:Poly I-C
Künstliche Polynukleotide als Interferon-Induktoren.